# A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

> **NCT06565195** · PHASE1 · RECRUITING · sponsor: **Prevail Therapeutics** · enrollment: 124 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** LY3962681
- **OTHER:** Placebo (aCSF)

## Key facts

- **NCT ID:** NCT06565195
- **Lead sponsor:** Prevail Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-27
- **Primary completion:** 2029-05-05
- **Final completion:** 2029-05-05
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06565195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06565195, "A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06565195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*